XRP's price action is at a pivotal juncture, defending a key long-term technical support level while recent regulatory approvals for Ripple Labs provide a fundamental backdrop. The cryptocurrency closed its monthly candle above the 33 Exponential Moving Average (EMA) cluster near $1.60, a level analysts view as critical for maintaining the asset's broader bullish structure. Despite a recent wick down to $1.50, the February open at $1.66 confirmed acceptance above this dynamic support.
Technically, the current price zone between $1.55 and $1.60 is seen as a major decision point. This area was the midpoint of XRP's breakout from a long consolidation in November 2024 and has since transitioned from resistance to support. A sustained break below could target the $1.30–$1.35 range. Market commentary frames the recent volatility, including a liquidity grab near $1.60–$1.61, as a structural reset typical of XRP's historical cycle behavior rather than a macro trend failure.
Fundamentally, Ripple Labs secured a significant regulatory win on February 2, 2026, receiving full approval for an Electronic Money Institution (EMI) license from Luxembourg's CSSF. This license allows Ripple to operate across the European Union under a unified framework, building upon similar approvals from the UK's Financial Conduct Authority. The company now holds over 75 regulatory licenses globally.
Meanwhile, investors are monitoring flows into XRP-related exchange-traded products (ETFs) as a potential short-term price catalyst. Total net assets across XRP spot ETFs stand near $1.19 billion. Analysts suggest that a pickup in daily ETF inflows could help absorb selling pressure and signal a rebound, as historical patterns have shown correlations between inflow periods and price consolidation or rallies.
